RSS Feeds
Search

Companies

Ester Neurosciences

A world leader in the discovery and development of innovative therapeutic products for the treatment of neurological disorders involving Neural Stress Response

The company in detail

Summary

Ester Neurosciences was established in 1997 by Medica Venture Partners to commercialize breakthrough discoveries pioneered by the Company's Chief Scientific Advisor, Prof. Hermona Soreq of the Hebrew University in Jerusalem, Israel. Ester Neurosciences is focused on developing therapeutic drugs to treat neurological related diseases. Ester's mission is to become a world leader in the discovery and development of innovative therapeutic products for the treatment of neurological disorders involving Neural Stress Response (NSR). Ester's goal and strategy are to utilize its versatile platform technology to develop a range of products, which will be commercially promoted by implementing a unique business model and creating strategic alliances with large pharmaceutical companies.

R&D

To view this information, you must subscribe to Pharmalicensing Intelligence.

Partnerships

To view this information, you must subscribe to Pharmalicensing Intelligence.

Deals

To view this information, you must subscribe to Pharmalicensing Intelligence.

Senior management

To view this information, you must subscribe to Pharmalicensing Intelligence.

Board of directors

To view this information, you must subscribe to Pharmalicensing Intelligence.

Contact details

To view this information, you must subscribe to Pharmalicensing Intelligence.

Head office

Ester Neurosciences
Ackerstein Towers,
Bldg. B.
10th Flr.
Herzlia Pituach
46120
Israel

Related companies

Related categories

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us